Daphne W Dumoulin

8PUBLICATIONS
66CO-AUTHORS
Immunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Artificial life and complex adaptive systemsPharmacogenomicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 05, 2026
Neurological complications induced by checkpoint inhibitors: characterising the clinical spectra.

|May 06, 2026
Automated Computational Flow Cytometry Correlates Decreasing Neutrophil-to-Lymphocyte Ratio to Improved Survival in NSCLC after Immune Checkpoint Blockade.

|Oct 16, 2025
Artificial intelligence for diagnosis and prognosis of thymic epithelial tumors: a systematic review.

Anna Salut Esteve Domínguez, Marlou Dimmers, Ties A Mulders

|Jul 25, 2025
TDM-Based Tailored Dosing of Durvalumab in Lung Cancer Patients: A Comprehensive Population Pharmacokinetic-Pharmacoeconomic Evaluation.

Fenna de Vries, Eric J F Franssen, Arthur A J Smit

|May 28, 2025
TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation study.

Mitchell Emmers, Marij J P Welters, Michelle V Dietz

|May 27, 2025
Folinic Acid Prophylaxis and Dose Adjustments Enable Safe Treatment with Pemetrexed in Patients with Renal Impairment.

Nikki de Rouw, Leila-Sophie Otten, Mart P Kicken

Pageof 2

Frequent Collaborators

3 joint publications

Ron H J Mathijssen

2 joint publications

Joachim G J V Aerts

2 joint publications

Rob Ter Heine

2 joint publications

Michel M van den Heuvel